For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage with the community.
Our primary contribution to healthcare is to discover and develop medicines and diagnostics that significantly improve people’s lives. This entails a commitment to working with many different partners to continuously and sustainably reduce the barriers that prevent or impede access to our products. Roche has received the Gold class award from RobecoSAM, the Dow Jones Sustainability Indices (DJSI) rating agency, within the pharmaceuticals, biotechnology and life sciences Industry for eleven years in a row.
Minimising our impact on the environment goes beyond the day-to-day operation of our business – we also build it into the design of our products as well as the management of our products at the end of their lives. It is important to us that our medicines and diagnostics products are developed, produced, used and managed at end of life in a responsible way.